Hensoldt's Order Book Is Bulging, but the Cash Register Is Still Playing Catch-Up

Two of the Street's most closely watched shops looked at the same set of Hensoldt numbers today and walked away with different verdicts. JPMorgan kept its Neutral rating with a EUR 100.0 price target, while Jefferies' Ben Brown reaffirmed his Buy call at EUR 98. The targets sit barely apart, which tells you the split isn't about the figures themselves — both houses agree revenue and adjusted operating profit, or adjusted EBITDA, came in ahead of consensus. The disagreement is about what those figures are worth.

That gap between a good quarter and a good investment case is the real story here. Defence names are judged against two separate yardsticks: progress versus the company's own prior plan, and progress versus what the market had already priced in. Hensoldt clears the first comfortably. The second is where it gets interesting.

A conservative guide — or a disappointing one?

Brown described the freshly raised outlook as conservative, according to dpa-AFX. The new revenue target of roughly EUR 2.8 billion nonetheless landed below the analyst consensus of more than EUR 2.9 billion. Both things can be true at once: a forecast can be set cautiously and still fall short of expectations. What matters for shareholders is that the second yardstick is the one the share price answers to.

The nine-month report for 2026, released today, gives the bullish camp plenty of ammunition. Revenue climbed 21.3% to EUR 1.863 billion, and adjusted EBITDA grew 33.0% to EUR 281 million — faster than sales, which is the relationship that counts. Reuters attributes the margin improvement to higher radar deliveries, giving the earnings beat a concrete operational explanation rather than leaving it as a spreadsheet curiosity.

Profitability tells the same story. The adjusted EBITDA margin reached 15.1% over the nine months, up from 13.7% a year earlier, and hit 20.6% in the third quarter of 2026. Management's full-year guidance points to an adjusted EBITDA margin of around 19% on revenue of about EUR 2.8 billion, raised from EUR 2.75 billion previously. Sensible investors will treat that standout quarterly margin as a peak rather than a new baseline — the company's own annual target is the better measuring stick.

Demand is not the problem

Order intake jumped 76.7% to EUR 3.564 billion in the nine-month period, and the order backlog hit a record EUR 10.367 billion. That is an extraordinary volume of contracted work, and it underpins the growth narrative. It is also not the same thing as revenue booked or profit earned. A backlog is a promise; deliveries are the payment. The interplay between the two deserves more attention than any single headline number.

There is further demand in the pipeline: should a PEGASUS order land before the end of 2026, the book-to-bill ratio could reach roughly 2.3. That is explicitly conditional and should not be read as a locked-in outcome.

The number that keeps the bulls honest

Here is where the enthusiasm needs a brake. Adjusted free cash flow was an outflow of EUR 104 million over the first nine months of 2026, though the third quarter alone delivered an inflow of EUR 32 million. A positive quarter is progress, not an all-clear. Earnings and cash flow answer different questions — one measures earning power, the other measures the money actually left over. Until Hensoldt shows a sustained positive free cash flow over a longer stretch, the case for paying up for the shares rests on faith as much as arithmetic.

Broader sector weakness among European defence stocks also weighed on the share price at points, meaning two forces overlapped: the market's reaction to Hensoldt's own guidance and sentiment toward the sector as a whole. A stock can make operational headway while labouring under demanding expectations or a softer industry mood — and a strong trading day doesn't prove the market has permanently re-rated the business either.

What to watch on 10 November

The capital markets day in London on 10 November 2026 is the next fixed point on the calendar. The most valuable thing Hensoldt could deliver there is a credible explanation of how a record backlog converts into profitable deliveries and, ultimately, into cash. Simply restating the scale of demand would leave the central valuation question unanswered.

The operational momentum is real, and the margin trajectory backs it up. But the more convincing next chapter would not be another guidance raise — it would be a free cash flow that finally turns sustainably positive. That is the test against which the optimism should be measured.